Baird Medical Collects Clinical Feedback at NASOIE 2026 Miami to Drive U.S. Expansion
Baird Medical showcased its proprietary microwave ablation technology at the NASOIE 2026 Annual Meeting in Miami, engaging top interventional endocrinologists in discussions on clinical applications and integration into practice. The clinical feedback collected will directly guide its U.S. commercial expansion strategy to broaden minimally invasive treatment access.
1. NASOIE Engagement
At the NASOIE 2026 Annual Meeting in Miami, Baird Medical presented live demonstrations of its minimally invasive microwave ablation system, hosting interactive sessions with leading interventional endocrinologists on procedural techniques and device performance.
2. Feedback-Informed Roadmap
Physician interactions yielded detailed input on lesion targeting, treatment protocols and patient selection, enabling Baird Medical to refine training materials and product features ahead of commercial roll-out.
3. Accelerated U.S. Expansion
Armed with clinical insights from NASOIE, the company plans phased launches in major hospital networks, aiming to expand adoption of its microwave ablation devices and increase patient access across the United States.